Mayo Clinic scientists are exploring an unusual but promising strategy to treat one of the deadliest bile duct cancers by turning milk into a microscopic delivery system for gene therapy. Their work ...

Detroit patients getting HEMGENIX report life‑changing results; trial data show 94% off prophylaxis at five years.

The global gene therapy market size is projected to expand significantly, with an estimated value of USD 19.3 billion by 2034 ...

Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...

Exclusive: Pre-chemotherapy tests previously did not look for gene variant that put some ethnicities at higher risk of serious side effects ...

A lab in Hawaiʻi is developing nanobodies, tiny proteins that help the immune system recognize and destroy cancer cells, ...

Ross Lamb had no idea that Angelina Jolie’s double mastectomy could have anything to do with his prostate cancer. Until he ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

A rare condition that's been around since the 1950s now has a modern treatment creating a promising future for those who've ...

Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan has ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...